IBDEI0AI ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4896,2)
 ;;=^267733
 ;;^UTILITY(U,$J,358.3,4897,0)
 ;;=198.2^^39^385^1
 ;;^UTILITY(U,$J,358.3,4897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4897,1,2,0)
 ;;=2^198.2
 ;;^UTILITY(U,$J,358.3,4897,1,5,0)
 ;;=5^Secondary Skin Cancer
 ;;^UTILITY(U,$J,358.3,4897,2)
 ;;=^267333
 ;;^UTILITY(U,$J,358.3,4898,0)
 ;;=238.2^^39^385^3
 ;;^UTILITY(U,$J,358.3,4898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4898,1,2,0)
 ;;=2^238.2
 ;;^UTILITY(U,$J,358.3,4898,1,5,0)
 ;;=5^Uncertain Behavior Neo Skin
 ;;^UTILITY(U,$J,358.3,4898,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,4899,0)
 ;;=239.2^^39^385^4
 ;;^UTILITY(U,$J,358.3,4899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4899,1,2,0)
 ;;=2^239.2
 ;;^UTILITY(U,$J,358.3,4899,1,5,0)
 ;;=5^Unspecified Neoplasm
 ;;^UTILITY(U,$J,358.3,4899,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,4900,0)
 ;;=V76.43^^39^385^2
 ;;^UTILITY(U,$J,358.3,4900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4900,1,2,0)
 ;;=2^V76.43
 ;;^UTILITY(U,$J,358.3,4900,1,5,0)
 ;;=5^Screening for malignant neoplasm
 ;;^UTILITY(U,$J,358.3,4900,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,4901,0)
 ;;=698.3^^39^386^2
 ;;^UTILITY(U,$J,358.3,4901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4901,1,2,0)
 ;;=2^698.3
 ;;^UTILITY(U,$J,358.3,4901,1,5,0)
 ;;=5^Prurigo Nodularis
 ;;^UTILITY(U,$J,358.3,4901,2)
 ;;=^70705
 ;;^UTILITY(U,$J,358.3,4902,0)
 ;;=698.2^^39^386^1
 ;;^UTILITY(U,$J,358.3,4902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4902,1,2,0)
 ;;=2^698.2
 ;;^UTILITY(U,$J,358.3,4902,1,5,0)
 ;;=5^Prurigo
 ;;^UTILITY(U,$J,358.3,4902,2)
 ;;=^100043
 ;;^UTILITY(U,$J,358.3,4903,0)
 ;;=132.1^^39^387^1
 ;;^UTILITY(U,$J,358.3,4903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4903,1,2,0)
 ;;=2^132.1
 ;;^UTILITY(U,$J,358.3,4903,1,5,0)
 ;;=5^Pediculosis, Body
 ;;^UTILITY(U,$J,358.3,4903,2)
 ;;=^266961
 ;;^UTILITY(U,$J,358.3,4904,0)
 ;;=132.0^^39^387^2
 ;;^UTILITY(U,$J,358.3,4904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4904,1,2,0)
 ;;=2^132.0
 ;;^UTILITY(U,$J,358.3,4904,1,5,0)
 ;;=5^Pediculosis, Head
 ;;^UTILITY(U,$J,358.3,4904,2)
 ;;=^266960
 ;;^UTILITY(U,$J,358.3,4905,0)
 ;;=132.2^^39^387^3
 ;;^UTILITY(U,$J,358.3,4905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4905,1,2,0)
 ;;=2^132.2
 ;;^UTILITY(U,$J,358.3,4905,1,5,0)
 ;;=5^Pediculosis, Pubic
 ;;^UTILITY(U,$J,358.3,4905,2)
 ;;=^266962
 ;;^UTILITY(U,$J,358.3,4906,0)
 ;;=696.3^^39^388^1
 ;;^UTILITY(U,$J,358.3,4906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4906,1,2,0)
 ;;=2^696.3
 ;;^UTILITY(U,$J,358.3,4906,1,5,0)
 ;;=5^Pityriasis Rosea
 ;;^UTILITY(U,$J,358.3,4906,2)
 ;;=^94726
 ;;^UTILITY(U,$J,358.3,4907,0)
 ;;=696.4^^39^388^2
 ;;^UTILITY(U,$J,358.3,4907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4907,1,2,0)
 ;;=2^696.4
 ;;^UTILITY(U,$J,358.3,4907,1,5,0)
 ;;=5^Pityriasis Rubra Pilaris
 ;;^UTILITY(U,$J,358.3,4907,2)
 ;;=^94729
 ;;^UTILITY(U,$J,358.3,4908,0)
 ;;=698.0^^39^389^2
 ;;^UTILITY(U,$J,358.3,4908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4908,1,2,0)
 ;;=2^698.0
 ;;^UTILITY(U,$J,358.3,4908,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,4908,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,4909,0)
 ;;=698.1^^39^389^3
 ;;^UTILITY(U,$J,358.3,4909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4909,1,2,0)
 ;;=2^698.1
 ;;^UTILITY(U,$J,358.3,4909,1,5,0)
 ;;=5^Pruritus Vulvae
 ;;^UTILITY(U,$J,358.3,4909,2)
 ;;=^100071
 ;;^UTILITY(U,$J,358.3,4910,0)
 ;;=698.9^^39^389^1
 ;;^UTILITY(U,$J,358.3,4910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4910,1,2,0)
 ;;=2^698.9
 ;;^UTILITY(U,$J,358.3,4910,1,5,0)
 ;;=5^Pruritic Disorder Unspecified
 ;;^UTILITY(U,$J,358.3,4910,2)
 ;;=^123977
